May/June • July/August • September/October • November/December

Chemotherapy for advanced colorectal cancer

Aromatase inhibitors in the treatment of breast cancer

Human resource costs of delivering chemotherapy and managing neutropenia

Cancer in America, 2004, by Linda Bosserman and I. Craig Henderson

Frank Arena on clinical trials in community practice

AnalyzeIt: software that provides the true cost of treatment regimens and services

Malignant paraganglioma, by Linda Bosserman and Paul Fitzgerald

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Bortezomib in multiple myeloma

Developments in antiemetic therapy

Oncology and hospice care

The cost-effectives of partial vs whole breast irradiation for early-stage breast cancer

William McGivney on how the NCCN guidelines relate to community oncology practice

PDA applications: drug reference guides

Extramammary Paget’s disease, by Venkatesh Rao and David Henry

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Predicting the outcome of breast cancer treatment

Chemotherapy for androgen-independent prostate cancer

Radiosurgical treatment of brain metastases in a community oncologic practice

Cancer-related anemia: when dollars- and cents—not science—dictate treatment

Satellite clinics: friend or foe?

Sizing up the competition

The benefits of personality assessment tools

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT

Bevacizumab in metastatic colorectal cancer and other settings

Platinum-based adjuvant therapy improves outcome in early NSCLC

The impact of medical visits for chemotherapy-induced anemia and neutropenia

Aromatase inhibitors in adjuvant therapy: promise and uncertainty, by Peter Ravdin

The smart medical oncology partnership, by Laurence Heifetz

von Hippel-Lindau syndrome, by Manop Pithukpakorn and Gladys Glenn

Medicare tries to get it right

Complete Table of Contents  FREE FULL TEXT IN PDF FORMAT